1. Home
  2. RKT vs IMCR Comparison

RKT vs IMCR Comparison

Compare RKT & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rocket Companies Inc.

RKT

Rocket Companies Inc.

HOLD

Current Price

$18.71

Market Cap

53.0B

Sector

Finance

ML Signal

HOLD

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

HOLD

Current Price

$36.52

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RKT
IMCR
Founded
1985
2008
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.0B
1.7B
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
RKT
IMCR
Price
$18.71
$36.52
Analyst Decision
Hold
Buy
Analyst Count
15
9
Target Price
$17.97
$67.00
AVG Volume (30 Days)
26.9M
338.1K
Earning Date
10-30-2025
11-06-2025
Dividend Yield
4.28%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,098,944,000.00
$379,590,000.00
Revenue This Year
$15.41
$32.31
Revenue Next Year
$72.61
$10.50
P/E Ratio
N/A
N/A
Revenue Growth
41.68
28.11
52 Week Low
$10.06
$23.15
52 Week High
$22.56
$40.72

Technical Indicators

Market Signals
Indicator
RKT
IMCR
Relative Strength Index (RSI) 51.76 49.05
Support Level $18.58 $35.35
Resistance Level $19.96 $40.71
Average True Range (ATR) 0.79 1.82
MACD -0.05 -0.45
Stochastic Oscillator 41.59 22.55

Price Performance

Historical Comparison
RKT
IMCR

About RKT Rocket Companies Inc.

Rocket Companies is a financial services company that was originally founded as Rock Financial in 1985 and is currently based in Detroit. Rocket Companies offers a wide array of services and products but is best known for its Rocket Mortgage business. The company's mortgage lending operations are split between its direct-to-consumer lending, which sees borrowers accessing the company's lending arm directly through either its mobile app or website, and its partner network where mortgage brokers and other firms use Rocket's origination process to offer loans to their customers. The company has rapidly gained market share in recent years and will also be the largest mortgage servicer in the US following its acquisition of the Mr. Cooper Group.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: